1502 related articles for article (PubMed ID: 28973344)
1. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
[TBL] [Abstract][Full Text] [Related]
2. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
[TBL] [Abstract][Full Text] [Related]
3. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
[TBL] [Abstract][Full Text] [Related]
4. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
Ballard RA; Truog WE; Cnaan A; Martin RJ; Ballard PL; Merrill JD; Walsh MC; Durand DJ; Mayock DE; Eichenwald EC; Null DR; Hudak ML; Puri AR; Golombek SG; Courtney SE; Stewart DL; Welty SE; Phibbs RH; Hibbs AM; Luan X; Wadlinger SR; Asselin JM; Coburn CE;
N Engl J Med; 2006 Jul; 355(4):343-53. PubMed ID: 16870913
[TBL] [Abstract][Full Text] [Related]
5. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
[TBL] [Abstract][Full Text] [Related]
6. Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ; Finer NN
Cochrane Database Syst Rev; 2007 Jul; (3):CD000509. PubMed ID: 17636641
[TBL] [Abstract][Full Text] [Related]
7. Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide.
Ballard RA; Keller RL; Black DM; Ballard PL; Merrill JD; Eichenwald EC; Truog WE; Mammel MC; Steinhorn RH; Rogers EE; Ryan RM; Durand DJ; Asselin JM; Bendel CM; Bendel-Stenzel EM; Courtney SE; Dhanireddy R; Hudak ML; Koch FR; Mayock DE; McKay VJ; O'Shea TM; Porta NF; Wadhawan R; Palermo L;
J Pediatr; 2016 Jan; 168():23-29.e4. PubMed ID: 26500107
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338
[TBL] [Abstract][Full Text] [Related]
9. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial.
Mercier JC; Hummler H; Durrmeyer X; Sanchez-Luna M; Carnielli V; Field D; Greenough A; Van Overmeire B; Jonsson B; Hallman M; Baldassarre J;
Lancet; 2010 Jul; 376(9738):346-54. PubMed ID: 20655106
[TBL] [Abstract][Full Text] [Related]
10. Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ; Finer NN
Cochrane Database Syst Rev; 2006 Jan; (1):CD000509. PubMed ID: 16437426
[TBL] [Abstract][Full Text] [Related]
11. Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ; Finer NN
Cochrane Database Syst Rev; 2001; (4):CD000509. PubMed ID: 11687084
[TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ; Finer NN
Cochrane Database Syst Rev; 2001; (3):CD000509. PubMed ID: 11686963
[TBL] [Abstract][Full Text] [Related]
13. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
14. Inhaled nitric oxide for premature infants with severe respiratory failure.
Van Meurs KP; Wright LL; Ehrenkranz RA; Lemons JA; Ball MB; Poole WK; Perritt R; Higgins RD; Oh W; Hudak ML; Laptook AR; Shankaran S; Finer NN; Carlo WA; Kennedy KA; Fridriksson JH; Steinhorn RH; Sokol GM; Konduri GG; Aschner JL; Stoll BJ; D'Angio CT; Stevenson DK;
N Engl J Med; 2005 Jul; 353(1):13-22. PubMed ID: 16000352
[TBL] [Abstract][Full Text] [Related]
15. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
[TBL] [Abstract][Full Text] [Related]
16. Inhaled nitric oxide (iNO) for preventing prematurity-related bronchopulmonary dysplasia (BPD): 7-year follow-up of the European Union Nitric Oxide (EUNO) trial.
Greenough A; Decobert F; Field D; Hallman M; Hummler HD; Jonsson B; Sánchez Luna M; Van Overmeire B; Carnielli VP; Potenziano JL; Mercier JC
J Perinat Med; 2020 Sep; 49(1):104-110. PubMed ID: 32892178
[TBL] [Abstract][Full Text] [Related]
17. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
[TBL] [Abstract][Full Text] [Related]
18. Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ; Finer N; Pennaforte T
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD000509. PubMed ID: 28045472
[TBL] [Abstract][Full Text] [Related]
19. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
[TBL] [Abstract][Full Text] [Related]
20. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
